Initiative unlocks new royalty-based income stream and expands platform utility for brands and users alike NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) — Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”), the media-tech platform at the intersection of gaming, college sports, and Gen Z engagement, last week unveiled plans to launch a secure digital asset platform as part of its Name, Image, and Likeness (NIL) initiative supporting the Company’s broader monetization strategy by introducing new revenue streams, expanding Gen Z engagement, and strengthening its data-driven value proposition. Building on its earlier announcement to explore digital NIL engagement models, the initiative leverages Brag House’s national footprint across 200+ NCAA campuses through its partnership with Learfield, enabling student-athletes...

PHOENIX, June 17, 2025 (GLOBE NEWSWIRE) — Fold Holdings, Inc. (NASDAQ: FLD) (“Fold” or the “Company”), the first publicly traded bitcoin financial services company, today announced that it has entered into an agreement for a $250 million equity purchase facility (“Facility”), with the net proceeds primarily intended to be used to acquire additional bitcoin for Fold’s corporate treasury. Pursuant to the Facility, the Company, in its sole discretion, has the right, but not the obligation, to issue and sell up to $250 million in newly issued shares of the Company’s common stock (“Common Stock”), subject to certain conditions, including that a registration statement covering the resale of the Common Stock be filed and declared effective by the Securities and Exchange Commission (“SEC”). The Company is not required to use the Facility...

Summary: SoundThinking has released its fourth annual Environmental, Social, and Governance (ESG) Report, emphasizing its commitment to advancing public safety through responsible use of technology for positive public safety outcomes. The report highlights the company’s progress toward addressing key societal challenges of public safety, by focusing on community well-being, social impact, transparent governance, and environmental sustainability. FREMONT, Calif., June 17, 2025 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI), a leading public safety technology provider, is proud to announce the release of its fourth annual Environmental, Social, and Governance (ESG) Report. The report highlights the company’s mission to facilitate technology solutions that help law enforcement become more efficient, effective, and...

MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, announced today that it has entered into a revolving credit facility (“the Credit Facility”), with National Bank of Canada (NBC). Knight has withdrawn C$60 million from the Credit Facility to fund a portion of the Paladin acquisition. The Credit Facility provides Knight with an initial borrowing limit of up to US$50 million, which is mainly intended to support the Company’s growth strategy and may also be used for working capital and other corporate purposes. The revolving credit facility is secured, and has an initial term of 3 years, which can be extended annually by an additional one-year terms. In addition, NBC has launched a syndication process,...

Tryg is hosting its Analyst Day 2025 today at Tryg’s headquarters. The event is dedicated to the sell-side analysts that cover the share. No new financial or strategic targets will be revealed – presentations from different business units will be shown. The presentation can be found on Tryg.com or attached here.AttachmentAnalyst Day 2025 Presentation

HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced a collaboration with Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), for current good manufacturing practice (cGMP) manufacturing of MT-601, Marker’s lead Multi-Antigen Recognizing (MAR)-T cell therapy. MT-601 is currently being investigated in the Phase 1 APOLLO study in patients with lymphoma who relapsed after anti-CD19 chimeric antigen receptor (CAR)-T cell therapy or for whom anti-CD19 CAR-T cell therapy is not an option (clinicaltrials.gov identifier: NCT05798897). Marker previously reported...

CARMEL, Ind., June 17, 2025 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS), covering two health insurers, with approximately 700,000 total members in Connecticut and Massachusetts. This medical policy will bring our national total coverage for PENFS to roughly 53 million, with more decisions from major payers still pending. NeurAxis’ PENFS technology, IB-Stim, is FDA-cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) and Pediatric Functional Dyspepsia (Nausea Symptoms) in adolescents 8-21 years old. IB-Stim is a non-surgical...

Oryzon’s CSO, Dr. Jordi Xaus, will participate in a Panel entitled “Industry Perspectives Discussion” on June 27 70-90% of PMS patients show autistic related features, including aggression Agitation/Aggression in PMS and other ASD-related patient subpopulations are the main focus of Oryzon’s VANDAM project included in the Med4Cure IPCEI project Oryzon is glad to participate as Sponsor of the congressMADRID and CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its Chief Scientific Officer, Dr. Jordi Xaus will be attending the 2025 Phelan-McDermid Syndrome Congress in Barcelona on June 26-29, which comprises the CureSHANK 2nd Annual Phelan-McDermid Syndrome Drug Development...

BOSTON, June 17, 2025 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that it will host a virtual key opinion leader (“KOL”) event on Wednesday, June 25, 2025 at 2:00 PM ET to discuss the significant unmet need and current treatment landscape for mutant-KRAS (“mKRAS”) driven pancreatic ductal adenocarcinoma (“PDAC”), one of the most lethal and underserved solid tumors. To register, click here. The event will feature insights from leading experts:Darrell Irvine, Ph.D. – Department of Immunology & Microbiology, The Scripps Research Institute, Howard Hughes Medical Institute Eileen O’Reilly, M.D. – FASCO Gastrointestinal Medical Oncologist at Memorial...

BOCA RATON, Fla., June 17, 2025 (GLOBE NEWSWIRE) — Totaligent, Inc. (OTCPK: TGNT), a leader in digital marketing, today announced a major milestone in its product development journey: the successful onboarding of a new technical leadership team and the adoption of a structured, bi-weekly sprint process. These advancements mark a significant leap forward in Totaligent’s mission to deliver a reliable, modern, and user-centric business intelligence platform. Over the past month, Totaligent has welcomed key engineering hires including a Lead Backend Developer and a Full-Stack Developer with a strong focus on UI/UX. The team has initiated foundational improvements aimed at elevating both the user experience and infrastructure stability. Recent Highlights:Infrastructure Reliability: Critical issues with SMS and email campaign delivery...